datetime,headline,summary,url,source
2025-04-09 00:03:42,Goldman Sachs Upgrades Eli Lilly and (LLY),,https://finnhub.io/api/news?id=313b6fbf76d21bee5f00c9023c377fa988b84da7b0122b093e33ad4081a42fa0,Fintel
2025-04-08 21:45:16,Eli Lilly (LLY) Gains As Market Dips: What You Should Know,"In the closing of the recent trading day, Eli Lilly (LLY) stood at $726.14, denoting a +0.33% change from the preceding trading day.",https://finnhub.io/api/news?id=29bf30547687de37560d484e63bcc743c79dfbcbbf17704bd07226a5b1a67453,Yahoo
2025-04-08 18:41:31,Jim Cramer on Eli Lilly and Company (LLY): “You Don’t Sell Lilly” — “David Ricks Is a Visionary”,"We recently published a list of Jim Cramer Nailed These 11 Stock Picks. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim Cramer discusses. On Thursday, April 3rd, the host of Mad Money opened the most recent show by addressing the growing […]",https://finnhub.io/api/news?id=9ec59903ded6c374629e22fa29683e14631ea950a5370b1923c0624fb1ffcf78,Yahoo
2025-04-08 17:58:13,"Biopharma Shakeup: Goldman Boosts J&J, Eli Lilly While Flagging Risks at Pfizer and AbbVie","Goldman updates coverage across major U.S. drugmakers, citing exclusivity risks, pricing power, and pipeline outlooks",https://finnhub.io/api/news?id=bc94276900cad2ebcc0b80e6d2292450595274f18897df2b28b0da16be1a544f,Yahoo
2025-04-08 17:26:00,Pfizer Stock’s Fall to ’97 Level Lifts Yield Near 8%. Dividend Looks Safe.,Pfizer Stock’s Fall to ’97 Level Lifts Yield Near 8%. Dividend Looks Safe.,https://finnhub.io/api/news?id=64adfabfb6730ff0a56254be2bb1e46d614053776b4fb83b36ad60432326f812,MarketWatch
2025-04-08 17:17:16,"Eli Lilly shares Jump ~5% after Goldman Sachs upgraded to ""Buy""","Eli Lilly Rises on Goldman Upgrade, Orforglipron Forecast Topped Street",https://finnhub.io/api/news?id=f8480b9751f67bbe6b2832266a21aac4ff7ce12e0a80af5338c1dd08ec2d2fd7,Yahoo
2025-04-08 14:27:55,"Trump Trade: Trump claims ‘no inflation,’ Medicare won’t cover obesity drugs","Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: TRUMP SAYS NO INFLATION: President Trump said via Truth Social, “Oil prices are down, interest rates are down (the slow moving Fed should cut rates!), food prices are down, there is NO INFLATION, and the long time abused USA is bringing in Billions of Dollars a week from the abusing countries on",https://finnhub.io/api/news?id=8d5f8527f82333e94b138326f7378b3106d1ce8ddd36bf49b67203fba3ea23b1,Yahoo
2025-04-08 14:09:00,LLY vs. NVO: Which Weight-Loss Drug Stock is a Stronger Play Now?,Both LLY and NVO are leading pharmaceutical companies specializing in diabetes and obesity treatments.,https://finnhub.io/api/news?id=e46f634729581f9640473d71eea6539df0983734ef7d778c626af11d32c984c3,Yahoo
2025-04-08 14:03:18,"Walgreens, CVS, & US drugmakers make big moves: What to know","Walgreens (WBA) stock is rising after the company reported better-than-expected second quarter earnings while preparing for privatization. Yahoo Finance Senior Health Reporter Anjalee Khemlani highlights the company's cost management strategy, CVS's (CVS) leadership changes amid similar challenges in the retail drug sector, and moves by US drug makers, like Merck (MRK), Johnson & Johnson (JNJ), and Eli Lilly (LLY), as they prepare for incoming tariffs. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",https://finnhub.io/api/news?id=4802859d758f4365de19e8df750d7be4ad395ac3a31a609b767e157d6ab882c0,Yahoo
2025-04-08 13:08:17,"Goldman turns cautious on major pharma names, sees select upside at Eli Lilly","Investing.com -- Goldman Sachs initiated coverage on several large-cap pharmaceutical companies, taking a cautious stance on Bristol-Myers Squibb (NYSE:BMY), Pfizer (NYSE:PFE), and AbbVie (NYSE:ABBV), while upgrading Eli Lilly (NYSE:LLY) to a Buy on strong growth prospects in obesity treatments.",https://finnhub.io/api/news?id=79226bcb7596285f28ccfc803c594c16b98e3dc7715b9d1f3c7d0d9b11ba1be3,Yahoo
2025-04-08 13:00:14,Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know,"Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.",https://finnhub.io/api/news?id=c4d6af9ced47a11b099c788170ef8f8a566784225b95410602626a445f41fb42,Yahoo
2025-04-08 07:36:39,"Humana, UnitedHealth, Other Insurers Jump On Medicare Advantage Payment Hike","Humana, UnitedHealth, Other Insurers Jump On Medicare Advantage Payment Hike",https://finnhub.io/api/news?id=3124e91e0bd1ae6fe94b276e7b9333c120cb0a9c18dec6d2fd691153dbffe212,DowJones
2025-04-07 20:24:00,"These Stocks Moved the Most Today: Apple, Tesla, GM, Nvidia, Super Micro, MicroStrategy, U.S. Steel, Alibaba, and More","Shares of Apple and Tesla tumble as both get their price targets cut by a longtime Wall Street bull, General Motors is downgraded, and MicroStrategy follows Bitcoin lower.",https://finnhub.io/api/news?id=a9b1ab951a2c8431e738e730c9eb728c7e37c45dc98df8f8ba69e268ee53708b,Yahoo
2025-04-07 19:18:12,Trump’s Tariff Threat Sparks Race to Find US Drug Manufacturers,"(Bloomberg) -- Drug manufacturers are rushing to reshape their supply chains amid President Donald Trump’s escalating tariff threats, leading to a potential windfall for contractors that make medications in the US.Most Read from BloombergHousing Agency Aims to Relocate Its DC HeadquartersThis Skinny Mexico City Tower Is Just 14 Feet Wide on One SideThe Irish Hot Press Is the Low-Tech Laundry Trick the World NeedsBoston Mayor Wu Embraces Trump Resistance as Campaign Heats UpTrump Order on CDFI Fu",https://finnhub.io/api/news?id=60e42533dd8176ff464ab8fd19b8da3ca2ad5369ceb37f68b03bb48318e2d57f,Yahoo
2025-04-07 17:43:00,Eli Lilly Stock Is Falling. It Isn’t Just About Tariffs.,The Trump administration did away with a Biden-era proposal to allow Medicare to start paying for weight loss drugs such as Eli Lilly’s Zepbound.,https://finnhub.io/api/news?id=68c3aab1b16adb4c2c400fedc93196f8b0c8a03daa7a8c114ace349f194fad39,Yahoo
2025-04-07 17:17:00,How Markets Solved the GLP-1 Shortage,How Markets Solved the GLP-1 Shortage,https://finnhub.io/api/news?id=6d5b891a48078a3a423d01a08d65af670717779b761a281021e44788c36c63e4,DowJones
2025-04-07 15:29:52,Novo preparing for early launch of weight-loss drug Wegovy in India,"Danish drugmaker Novo Nordisk is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better compete with rival Eli Lilly in the populous nation, two sources familiar with the plans told Reuters.  Novo, which had earlier planned for a 2026 launch of the drug, is now looking to begin selling Wegovy in India ""this year, probably in the next few months,"" sources told Reuters on condition of anonymity as they were not authorized to talk to the media.",https://finnhub.io/api/news?id=b9037910fe474b06fdeef672bb0c6d8d8d34637bfd0be0e6a87d17ad2a860874,Yahoo
2025-04-07 13:14:00,NVO & LLY Shares Down on Exclusion of Obesity Drugs From Medicare,"CMS keeps out LLY and NVO's obesity drugs from Medicare coverage. Medicare, at present, does not cover obesity drugs if they are solely prescribed for weight loss.",https://finnhub.io/api/news?id=1ab5d0b1eb383901fd32646ebc59f57731260538db7099efe5442a4696fe9c10,Yahoo
2025-04-07 12:58:00,"These Stocks Are Moving the Most Today: Apple, Tesla, GM, JPMorgan, Nvidia, MicroStrategy, Alibaba, Lilly, and More","Shares of Apple and Tesla tumble as both get their price targets cut by a longtime Wall Street bull, while bank stocks such as JPMorgan Chase fall on fears of a global recession.",https://finnhub.io/api/news?id=40476202a94a7d91bf9fd9dd8b66736f451b531769515ff7b4fc9947a87a5da9,Yahoo
2025-04-07 12:37:00,Big Pharma Stocks Dive Amid Trade War Jitters & Inflation Woes,"Shares of pharma giants like PFE, J&J, AZN, MRK and ABBV decline on investor concerns that retaliatory tariffs could drive up drug prices for U.S. consumers.",https://finnhub.io/api/news?id=cbecc3924b2c8557ce93a1fc8eeeb9d241d9b78ca1f7b2dad7572c7496db12fe,Yahoo
2025-04-07 11:13:30,Obesity drugs won’t be covered by Medicare under 2026 CMS policy,"This decision is a blow for Eli Lilly and Novo Nordisk, who had both previously endorsed the proposed expansion.",https://finnhub.io/api/news?id=57aef34cf228931da27914a31eb4094317cc4b8283795a78ca01d29006f22607,Yahoo
2025-04-07 09:55:00,Trump rejects Biden administration plan to let Medicare cover obesity drugs,"The decision is a setback for GLP-1 drugmakers, though it's not entirely surprising given the Trump administration’s focus on curbing government spending.",https://finnhub.io/api/news?id=90bffb9bdf01f9a96b061c9c3ffe4a60dc35d04d604188c33bcccd5f0a7632c0,Yahoo
2025-04-07 08:00:00,"US vs. EU: When it comes to novel Alzheimer’s drugs, regulators can’t seem to agree",The FDA is much more flexible in approving first-in-class drugs compared to European regulators.,https://finnhub.io/api/news?id=190d0bbb9c7bdc053cb664eefdcf3bc706abbf031e324864335ba3c1c6c1e18f,Yahoo
2025-04-07 01:00:00,This Type of Cholesterol Is a Risk Factor for Heart Disease. Emerging Drugs from Lilly and Amgen Could Treat It.,This Type of Cholesterol Is a Risk Factor for Heart Disease. Emerging Drugs from Lilly and Amgen Could Treat It.,https://finnhub.io/api/news?id=b7ec6c2898e4bf25509b977dd64e9db96e238b62935cf4565e146289f9f5ef27,MarketWatch
2025-04-06 20:51:11,Is Eli Lilly and Company (LLY) the Best Beginner Stock?,"We recently published a list of Starter Stock Portfolio 12 Safe Stocks to Buy. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best beginner stocks. The US stock market has experienced a turbulent first quarter of 2025, marked by increased volatility and negative […]",https://finnhub.io/api/news?id=bf01c4e8b02c7b242c84792f06d41b1c1edce0b0fb70aed2cbf58a9fa58aff39,Yahoo
2025-04-06 12:00:00,2 Top Growth Stocks to Buy and Hold for the Next 20 Years,Let's consider two great examples: Eli Lilly (NYSE: LLY) and Veeva Systems (NYSE: VEEV).  Here's what investors need to know about these market leaders that could deliver outsized returns in the next two decades.  Eli Lilly is grabbing headlines thanks to medicines like Mounjaro for diabetes and Zepbound for weight management.,https://finnhub.io/api/news?id=7ecc4c687aa304316a11301c9af8867658be2e11c5395b71e4027e2e3821fb57,Yahoo
2025-04-06 10:44:00,3 Dividend Stocks to Buy and Hold for the Next Decade,"What should investors do when stocks are tanking over the short term?  Three Motley Fool contributors think they've found great dividend stocks to own for the long term that pay you to wait for better days.  Here's why they picked AbbVie (NYSE: ABBV), Amgen (NASDAQ: AMGN), and Eli Lilly (NYSE: LLY).",https://finnhub.io/api/news?id=270f124883da0590a10adac527c11e2602c44684abe3ad8ccc97c2f6119c14e3,Yahoo
2025-04-05 17:52:25,Eli Lilly (NYSE:LLY) Announces Positive Phase 2 Results For siRNA Therapy Amid 6% Quarterly Price Dip,"Eli Lilly (NYSE:LLY) has recently announced several developments, including positive Phase 2 results for their siRNA therapy lepodisiran and the expansion of their digital healthcare platform, LillyDirect, to support Alzheimer's patients. Despite these advancements, Eli Lilly's stock fell 6% in the last quarter. This movement came amid a broader market downturn, with substantial declines in major indices such as the Dow and S&P 500 due to escalating tariff issues and growing economic...",https://finnhub.io/api/news?id=c8479bf9c3a1933e5c616fe59295cecf162073d332ee577ad2225c60cfcf1125,Yahoo
2025-04-05 00:00:08,"Eli Lilly, Novo Stocks Dive After Medicare Excludes Weight-Loss Drugs","The Trump administration finalized new Medicare and Medicaid policies late Friday, but left out weight-loss drugs. Eli Lilly stock skidded.",https://finnhub.io/api/news?id=a8e05d1505d4168bc47fd687a1473adbc17034f70c85e85717600cba00a5b63d,Yahoo
2025-04-04 21:54:48,"Jim Cramer on Eli Lilly (LLY) – “Own Eli Lilly, Going to a Trillion Dollars!”","We recently published a list of Jim Cramer’s Take on These 10 Stocks. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim Cramer discusses. On Wednesday, Jim Cramer, the host of Mad Money, shared his concerns about President Donald Trump’s approach […]",https://finnhub.io/api/news?id=531256d09d141ae02490f6e77b23dbef2f2e1848545fdd915fe73a65bb5826a0,Yahoo
2025-04-04 21:17:17,Trump admin. to reportedly drop Medicare GLP-1 plan,"The Trump administration has decided not to back a Biden administration plan that would have allowed Medicare to pay for obesity drugs, according to a report from Bloomberg. Shares of both Eli Lilly (LLY) and Novo Nordisk (NVO) traded lower on the news. Learn more in the video above. To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here.",https://finnhub.io/api/news?id=9c52700a95c70e33f32c2546f3ac01e7412649ed46d28660718d0e8dd3ceeeb2,Yahoo
2025-04-04 18:23:00,"Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies","Stocks to Watch: Eli Lilly, Novo Nordisk, Hims & Hers, Maxeon Solar Technologies",https://finnhub.io/api/news?id=5d5ed445c3482d6fed7fd8578939ca92ab711fd29e299f034aad7478a01d1aa9,MarketWatch
2025-04-04 16:41:00,"Edesa Biotech Appoints Weiler as CFO, Succeeding Lemieux","Edesa Biotech Appoints Weiler as CFO, Succeeding Lemieux",https://finnhub.io/api/news?id=efee9600112a908848fdf21c5ad3eca3f8482e5942f033516b280bb15e6755ed,MarketWatch
2025-04-04 16:31:00,Eli Lilly & Co. stock underperforms Friday when compared to competitors,Eli Lilly & Co. stock underperforms Friday when compared to competitors,https://finnhub.io/api/news?id=9a1cc642c0c952b257a50dc1801e4c4b476a39211f41ed5cb1113c17b2270057,MarketWatch
2025-04-04 14:57:37,Sangamo Therapeutics: Scope Goes Beyond That Of Recent Eli Lilly Licensing Deal,"Sangamo Therapeutics, Inc.'s $18M Eli Lilly deal boosts CNS genomic medicines. Fabry gene therapy data in 2025 is key for investors. Click for my SGMO stock update.",https://finnhub.io/api/news?id=6f98aa3397cc409f6c1bf3034d53536a90ac0b780c700cf099537c7b7d92efa8,SeekingAlpha
2025-04-04 13:40:57,Jim Cramer Says You Should ‘Stay Long’ Eli Lilly (LLY) Because of These Reasons,"We recently published a list of Jim Cramer Was Talking About These 10 Stocks Amid Trump’s Trade Wars. In this article, we are going to take a look at where Eli Lilly (NYSE:LLY) stands against other stocks that Jim Cramer was talking about amid Trump’s trade wars. Jim Cramer in a latest program on CNBC […]",https://finnhub.io/api/news?id=694cbf613140637d3f9465f784904f25178a8d72dfd7ea431dd4675aac2aa0fe,Yahoo
2025-04-04 13:01:12,"1 Ideal Buy From 23 ""Safer"" April Dividend Dogs In 50 Fortune World's Most Admired Companies (FWMAC)",Discover top investment opportunities: Fortune 50 highlights admired companies with strong dividends. Read the full list of stock picks here on Seeking Alpha.,https://finnhub.io/api/news?id=32d998c2fae31ad28c34ec6e39c3013ff821c16b7608d3c185838636ef8c20c7,SeekingAlpha
2025-04-03 23:28:20,Top 50 High-Quality Dividend Growth Stocks For April 2025,8 high-quality dividend stocks with top return potential for 2025. Click here for a detailed analysis.,https://finnhub.io/api/news?id=7e164db62b82712493c6c3ac3658c57e9cc854ca8b7bd166867e1c6f8ba49c6d,SeekingAlpha
2025-04-03 23:22:00,Voya Corporate Leaders Trust Fund B Q4 2024 Commentary,"For the quarter, Voya Corporates Leaders Trust Fund Series B underperformed its benchmark, S&P 500 Index on a net asset value basis, primarily due to selection effects.",https://finnhub.io/api/news?id=748f3481ec49c2de282915ec9d756a88810d29de334c3771b85e2474e5315fc5,SeekingAlpha
2025-04-03 16:45:00,Shares of Sangamo Therapeutics Rally on Licensing Deal With Eli Lilly,Shares of Sangamo Therapeutics Rally on Licensing Deal With Eli Lilly,https://finnhub.io/api/news?id=15e650d6627ab1afef50fab6f0596ba8355833094c355939abb6aa20508f4199,MarketWatch
2025-04-03 16:31:00,Eli Lilly & Co. stock underperforms Thursday when compared to competitors,Eli Lilly & Co. stock underperforms Thursday when compared to competitors,https://finnhub.io/api/news?id=f3bf30a5e0c4d7051d6abb443519b95c6ca51ba578fb023c13170f28bd4598b0,MarketWatch
2025-04-03 16:30:00,Sangamo Therapeutics Enters Capsid License Agreement With Lilly,Sangamo Therapeutics Enters Capsid License Agreement With Lilly,https://finnhub.io/api/news?id=b732458dfff5c876602d24fa781ae555a89c644edf7cc718097dbd2e6354a846,MarketWatch
2025-04-03 14:48:00,BIIB's Experimental Alzheimer's Drug Gets FDA Fast Track Tag,The FDA's fast track designation will facilitate rapid development and expedited review of Biogen's Alzheimer's disease candidate.,https://finnhub.io/api/news?id=45f13dc2652f61e0ea1627320908e91a237ee432e708856e48db630703054bfe,Yahoo
2025-04-03 13:51:14,Eli Lilly Vs. Hims & Hers In DTC Weight Loss Market? - There Is Only One Winner,,https://finnhub.io/api/news?id=7567bd4a26b1ef7720adc6e39994b0bfb5a0d22993435f8442f501f4c0176b4d,SeekingAlpha
2025-04-03 13:00:09,How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings,Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.,https://finnhub.io/api/news?id=c402b362cc0772d387e0f0d179d153c70f25c81ed2a2858a113bb6a50deabdcf,Yahoo
2025-04-03 07:58:14,Knownwell Connects with LillyDirect to Increase Access to Independent Comprehensive Metabolic Care Options for Patients Across the U.S.,"BOSTON - knownwell, an in-person and virtual, weight-inclusive primary care and metabolic health company, today announced it will be listed as the latest care provider option on Eli Lilly and...",https://finnhub.io/api/news?id=041388654298f02dfcf7e32ca9d6fdb9a1c0fda19d3e016d80e24d7db3c1f304,Finnhub
2025-04-02 22:03:35,Big Pharma Avoids Worst-Case Tariff Scenario,"Drugmakers breathed a sigh of relief Wednesday after President Trump didn’t announce pharmaceutical tariffs.  Plus, language in the executive order indicated medicines were exempted from the reciprocal tariffs that Trump did announce.  Drugmakers were combing over the executive order to clarify the exemption language in the executive order and to make sure they won’t be hit by any other tariff provisions, such as the 10% “baseline” tariff.",https://finnhub.io/api/news?id=e56792421f40cd13cbd5b94e4465a2bf24427e7b41aded3c7608a2d37bd75b9a,Yahoo
2025-04-02 20:32:55,Hims Claws Back After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch,Hims stock clawed higher Wednesday though analysts laid out low expectations for Him & Hers' branded tirzepatide.,https://finnhub.io/api/news?id=7c0562153c3a0a24c8e0163dd5e00d1acff00381e6b683704e1d001b43392927,Yahoo
2025-04-02 19:21:47,Primary care firm knownwell joins LillyDirect to offer weight-management services,"Primary care company knownwell said on Wednesday it will provide health and weight-management services on Eli Lilly's direct-to-consumer online healthcare platform, LillyDirect. Patients on LillyDirect will have access to physicians from knownwell for personalized services, knownwell said. The company offers in-person and virtual primary care, nutrition counseling and behavioral health services, covered through patients' insurance.",https://finnhub.io/api/news?id=b85daa67b6fd5a153f9e1f783c36dc23494231170ebc2a46059dc492c3567e88,Yahoo
2025-04-02 18:12:00,"Hims & Hers Zepbound Offering Won’t Bring Needed Sales Boom, Analysts Say","Investors worry patients won’t make that price leap and that Hims, which has built its business on affordable healthcare, will struggle to meet its revenue goal.",https://finnhub.io/api/news?id=dd36105d6190d2d1254e5d8f803f0ed0e88f7e1384aafb2a41f748400a0a8a3f,Yahoo
2025-04-02 15:53:55,Hims Dives After Its Lilly-Rivaling Obesity Plan Faces An Unexpected Hitch,Hims stock reversed lower Wednesday as analysts laid out low expectations for Him & Hers' branded tirzepatide.,https://finnhub.io/api/news?id=c6af30fc41669b4c2f928a17a02f2a221c6afd74fa91c6ef29716abd94d981f8,Yahoo
2025-04-02 13:43:00,"PFE, MRK, LLY & Other Drug Stocks Down Amid Tariff Jitters","Stocks of PFE, MRK, ABBV, LLY and others declined on Tuesday due to uncertainty surrounding Trump's proposed tariffs on pharma imports.",https://finnhub.io/api/news?id=611d6c8d7611d0acc68c83eed246c9f8d45eefbfc4007a723fb61da60186c604,Yahoo
2025-04-02 11:50:00,Drug Industry Offers Tepid Pushback to Kennedy’s FDA Job Cuts,Drug Industry Offers Tepid Pushback to Kennedy’s FDA Job Cuts,https://finnhub.io/api/news?id=1c51ec2a04ac175f6294f5ba97b2649a1cc9e9032ba4698ec15736e9697c440b,MarketWatch
2025-04-02 10:46:00,Why April Could Be a Huge Month for Eli Lilly Stock,"Eli Lilly (NYSE: LLY) is the most valuable healthcare company in the world, worth more than $700 billion.  Over the past 12 months, however, the stock's performance has been fairly lackluster, rising by just around 6%.  Investors are beginning to scoff at its expensive price tag, with Eli Lilly trading at more than 70 times its trailing earnings.",https://finnhub.io/api/news?id=cc10b6c3649522d05974a57af0638b28ef28fdc6c881ad8d83a33d1ae92bb95b,Yahoo
2025-04-02 09:06:00,Altria vs. Eli Lilly: What's the Better Stock for Dividend Investors?,"Tobacco giant Altria (NYSE: MO) provides a tremendously high dividend yield of 7%, which is well above the S&P 500 index average of 1.3%.  Meanwhile, pharma company Eli Lilly (NYSE: LLY) offers a much lower yield of less than 1%, but its dividend growth rate has been far more impressive.  Which stock is the better buy if your priority is to collect a lot of dividend income?",https://finnhub.io/api/news?id=295105eec3d3c23d8fd59da0964391672ce746007e4a7860bbf9e4467bd6c861,Yahoo
2025-04-02 04:11:08,Compounding Problems: Recent Decisions On Tirzepatide Highlight Interplay Between FDA Anti-Compounding Enforcement And Private Intellectual Property Rights,"Earlier this month, a federal district court denied the Outsourcing Facilities Association's preliminary injunction motion, which sought to preclude FDA from taking enforcement action against...",https://finnhub.io/api/news?id=80066120837ab3751297b83c67262e0924eed3064dd374a719b9c193dcc26690,Finnhub
2025-04-01 23:38:00,"Hims & Hers Expands Weight Loss Offering, Adds Lilly’s Zepbound to Platform","Hims & Hers Health  said it is expanding its weight-loss offerings with the addition of  Eli Lilly  & Co. Zepbound and generic liraglutide.  The telehealth-consultation platform on Tuesday said it aimed to bring its customers more treatment options to best suit their needs.  “We’ve now expanded that choice even further by adding access to generic liraglutide and branded tirzepatide through our platform,” the company said.",https://finnhub.io/api/news?id=eefdfe9c27a794d1da174d4d96141ac9b8d70b207e28c54c519d26cc598eb518,Yahoo
2025-04-01 21:38:08,Hims & Hers Stock Surges as Telehealth Platform Adds Eli Lilly Weight-Loss Drugs,Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment Mounjaro to its telehealth platform.,https://finnhub.io/api/news?id=e6b49f1119274156eaae4fb1b2f7d471270564dafa6c2021ad0ad101b170a933,Yahoo
2025-04-01 20:59:09,Eli Lilly and Company (LLY): The Best Healthcare Stock to Buy According to Billionaires,"We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best healthcare stocks to invest in. Healthcare stocks experienced a challenging year in 2024, lagging behind high-growth sectors like tech […]",https://finnhub.io/api/news?id=c056e161078cf9ceea195a3b699ca0af7593241ff7c97f66930f8683c663b08c,Yahoo
2025-04-01 20:48:47,"Hims & Hers adds Eli Lilly GLP-1 drugs, Johnson & Johnson setback","Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination to discuss some of the top stories of the trading day, including Johnson & Johnson's (JNJ) setback in its litigation. Additionally, Hims & Hers (HIMS) expanded its offerings, adding Eli Lilly's (LLY) GLP-1 drugs to its telehealth platform, following its earlier partnership with Novo Nordisk. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",https://finnhub.io/api/news?id=16c699b332de57394a58b8070aba6ae3a3bec745ff109be2aa73ba7125a2e757,Yahoo
2025-04-01 20:15:16,Hims Stock Jumps After Adding Eli Lilly's Obesity Drug To Its Platform,Hims stock surged Tuesday after the compounding pharmacy said it would sell Eli Lilly's branded weight-loss drug on its telehealth platform.,https://finnhub.io/api/news?id=53c3a03eff706b7ad16a906ef211df0bea2b8da20015bab4eb49fde725f274ee,Yahoo
2025-04-01 20:00:50,Sector Update: Health Care Stocks Fall Late Afternoon,"Health care stocks declined late Tuesday afternoon, with the NYSE Health Care Index dropping 2.1% an",https://finnhub.io/api/news?id=27dd22c7ea89dfbf74be7ad3b60e982777bb519a71dde1eec9895b61c00487f9,Yahoo
2025-04-01 18:31:00,Wilbur Ross Has Thoughts on Trump’s Tariffs,Wilbur Ross Has Thoughts on Trump’s Tariffs,https://finnhub.io/api/news?id=5fdd26e14780f0077d9cc7de6cc31bc07a4e4e420a17d53954514c66107582da,MarketWatch
2025-04-01 17:52:41,Hims & Hers to sell Lilly's weight-loss drug on its telehealth platform,"Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's weight-loss drug, as it widens its offerings to offset any impact from impending restrictions on selling copies of Novo...",https://finnhub.io/api/news?id=d44eb5db3334183245c7e4eb96ea8d232c54bf26afa8e6095b08d0af79a35916,Finnhub
2025-04-01 17:39:33,Hims & Hers to sell Lilly's Zepbound on its telehealth platform,"The telehealth firm joins its peers such as Teladoc and LifeMD to offer Lilly's Zepbound ahead of restrictions on selling copies known as compounded drugs.  The company said it will offer both branded versions of Lilly's tirzepatide - the active ingredient in weight-loss drug Zepbound and diabetes medicine Mounjaro - as well as generics of Novo Nordisk's diabetes drug, liraglutide.  Hims & Hers previously only offered cheaper versions of Novo's weight loss drug Wegovy.",https://finnhub.io/api/news?id=9d64c2169b2a055d7752334dd0bc17c3016b2b31cbf8ea718efa40099e3db951,Yahoo
2025-04-01 17:32:23,Statement: Lilly has no affiliation with hims & hers,"INDIANAPOLIS, April 1, 2025 - Eli Lilly and Company has no affiliation with hims & hers. Zepbound can be prescribed by any licensed healthcare professional. People who are commercially insured with...",https://finnhub.io/api/news?id=87d10d661a04fbd175e7d8f2773c5cf823c2dc92a78cda175a32a8cce6f06a89,Finnhub
2025-04-01 17:22:28,Trump's Pharma Tariffs Could Blow Up Global Drug Supply Chains,A 25% levy is looming--and Big Pharma's billion-dollar operations in Europe may be on the chopping block.,https://finnhub.io/api/news?id=804f6996d4f5fe1e72076dd07b90cf1be0fee89517693ac8ed0400ddbfb5c174,Yahoo
2025-04-01 17:15:00,Hims & Hers Adds Eli Lilly's Zepbound in Expansion of Weight-Loss Offerings -- 2nd Update,By Sabela Ojea Hims & Hers Health said it is expanding its weight-loss offerings with the addition of Eli Lilly & Co.'s Zepbound and generic liraglutide. The telehealth-consultation platform...,https://finnhub.io/api/news?id=d0493951bbf52856d464476bdc16341a387da4a8b12f6c2c770709e3b9fad28c,Finnhub
2025-04-01 16:31:00,Eli Lilly & Co. stock outperforms competitors despite losses on the day,Eli Lilly & Co. stock outperforms competitors despite losses on the day,https://finnhub.io/api/news?id=1b506907e11ea6c18bcd67be5dbb12b3e10a3d666143ee5495bc484b311b6cdb,MarketWatch
2025-04-01 16:00:43,Update: Eli Lilly Reportedly Sues More Drug Compounders for Copying Weight Loss Drug,(Updates with statement from Eli Lilly spokesperson in the last two paragraphs.) Eli Lilly (LLY),https://finnhub.io/api/news?id=3c901a9d215a9dc9744931b58f9426051a1d4c83f91c75bc084457ff8414facd,Yahoo
2025-04-01 15:38:06,"Eli Lilly, Roku among others added to Wells Fargo's tactical ideas list","Investing.com -- Wells Fargo has released its Q2 2025 Tactical Ideas list on Tuesday, highlighting 10 stocks across nine subsectors that analysts believe could see significant catalysts in the coming quarter.",https://finnhub.io/api/news?id=4ec367cf4224a39d8f68e6b37a3b6ec3fafd62fe775cd1dc6d908a2ebf032126,Yahoo
2025-04-01 15:13:00,Eli Lilly is coming after makers of copycat versions of Zepbound,"Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs, Mounjaro and Zepbound.",https://finnhub.io/api/news?id=e1940083e6d5128ca8398ffba4f1ca532db0f67768bc9c8543b78516be9f30e0,Yahoo
2025-04-01 15:04:45,Eli Lilly and Ralph Lauren included in BofA's 'Top 10 US Ideas for Q2 2025' list,"Investing.com -- Bank of America released its Top 10 US Ideas for Q2 2025 note on Tuesday, highlighting stocks the firm believes have significant market and business-related catalysts in the months ahead.",https://finnhub.io/api/news?id=44d2b4dd3b2d73af2cd91cbb3d9a48eb23905cd01f619effe375ce099143cc8d,Yahoo
2025-04-01 13:47:31,Is Eli Lilly and Company (LLY) the Best Gene-Editing Stock to Buy?,"We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best gene-editing stocks to buy. Gene editing is an advanced medical technique within gene therapy that involves precisely modifying an individual’s DNA to […]",https://finnhub.io/api/news?id=4e9ece4c290d21d659e24fee6cd3958ca86fe51413f5c4bae550909f2d27771d,Yahoo
2025-04-01 09:37:00,Where Will Eli Lilly Be in 1 Year?,The company has a looming opportunity to grab the booming GLP-1 agonist market by the horns.,https://finnhub.io/api/news?id=994d05a53c3762023e3eed311434f45215a371d4cebd355cf87da5ea912e7921,Yahoo
2025-03-31 21:45:15,Eli Lilly (LLY) Rises But Trails Market: What Investors Should Know,"In the most recent trading session, Eli Lilly (LLY) closed at $825.91, indicating a +0.41% shift from the previous trading day.",https://finnhub.io/api/news?id=51c11e32ee55710e9e29881813cbb5fa19f626fed2b8d9b7770bbcdb480bc7da,Yahoo
2025-03-31 17:29:00,Eli Lilly (NYSE:LLY) Unveils Positive Phase 2 Results For Heart Disease Therapy Amid 5% Share Dip,"Eli Lilly (NYSE:LLY) experienced a 6% increase in price over the last quarter, coinciding with several major developments. The company reported strong financial results, with significant year-over-year earnings growth. Further bolstering its stock was the announcement of successful Phase 2 results for lepodisiran, which reduced lipoprotein(a) levels, a genetic heart disease risk factor. Additionally, the company's expansion in digital healthcare and strategic partnerships, like those with...",https://finnhub.io/api/news?id=96fe43f7185e471142f3db2093a873bcdc04583e90cc5d71687f88fdee8dd74b,Yahoo
2025-03-31 16:39:15,Eli Lilly's Cholesterol Drug Reduces Genetic Heart Disease Risk Factor By 93.9%,"Eli Lilly And Co (NYSE:LLY), on Sunday, announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA (siRNA) therapy designed to lower the production of lipoprotein(a) [Lp(a)], a genetically inherited risk factor for heart disease. In the Phase 2 ALPACA study, lepodisiran significantly reduced Lp(a) levels by an average of 93.9% over the 60 to 180-day period after treatment with the highest tested dose (400 mg), meeting the primary endpoint. Participants who recei",https://finnhub.io/api/news?id=4c740a938097d3f3cf5c3d4092faa9fe350ef7ae619a7828a8e2d38d8d80e2ca,Yahoo
2025-03-31 14:34:09,Biotech Stocks Q1 2025 Recap: Winners And Underperformers,,https://finnhub.io/api/news?id=fca2009a34592e24b4f3882a92027b0a12ab50ad4e5643e6b09744fc6b98a472,SeekingAlpha
2025-03-31 14:00:00,Is the Future Bleak for SAVA Stock Following Another Setback?,The failure of yet another late-stage study on its Alzheimer's disease candidate puts Cassava Sciences in a pickle with uncertain growth prospects.,https://finnhub.io/api/news?id=7d84c3daf4c126a4152f12fd1ffd0164e0ab8c50603f755bccb5b231201ede9e,Yahoo
2025-03-31 11:52:57,Eli Lilly’s lepodisiran cuts lipoprotein(a) by 93.9% in Phase II trial,The Phase II study found that lepodisiran significantly reduced levels of genetically inherited cardiovascular risk factor.,https://finnhub.io/api/news?id=cc1aecd576ccce6659325effc82ea05199bb2649bfc8534678daca5cced4ee9c,Yahoo
2025-03-31 11:52:22,"Lilly's lepodisiran reduced levels of genetically inherited heart disease risk factor, lipoprotein(a), by nearly 94% from baseline at the highest tested dose in adults with elevated levels","INDIANAPOLIS - Eli Lilly and Company today announced positive Phase 2 results for lepodisiran, an investigational small interfering RNA therapy designed to lower the production of lipoprotein [Lp],...",https://finnhub.io/api/news?id=9a76a18bc8076fc11b5274aeb0eb1ecbd1c4a78f585aa7086e59ab07f0007058,Finnhub
2025-03-31 11:15:00,PGIM Jennison Global Opportunities Fund Q4 2024 Commentary,"The PGIM Jennison Global Opportunities Fund returned -0.6%, holding up slightly better than the MSCI ACWI Index. Click here to read the full commentary. ",https://finnhub.io/api/news?id=4e3ccc7be59fb7d5a1ce2d2968438f82e1cc05399ebdc5fbccad36a50cfe99f3,SeekingAlpha
2025-03-31 10:02:00,Hartford Large Cap Growth ETF Q4 2024 Commentary,The Hartford Large Cap Growth ETF outperformed the Russell 1000 Growth Index during the quarter. Read more here.,https://finnhub.io/api/news?id=bf78413d48a567a0da9ddb002836cce45043b5ae2b518a354a64f1e316b804b7,SeekingAlpha
2025-03-31 07:23:19,"In the obesity triple-agonist blockbuster race, a familiar battle looms: Novo vs. Lilly",The two market leaders are targeting new obesity alternatives in their pipelines with an eye toward a triple threat.,https://finnhub.io/api/news?id=3a534c993744a33991869ecb461440bc7086bcd4bbcca27c5daa6e8c049f08e9,Yahoo
2025-03-31 07:12:11,Eli Lilly Phase 2 Lipoprotein(a) Study Hits Primary Endpoint,By Colin Kellaher Eli Lilly said an experimental drug nearly eliminated an inherited type of bad cholesterol at its highest dose in a mid-stage study. Eli Lilly on Sunday said the Phase 2...,https://finnhub.io/api/news?id=538f9e33a3381e9835765c9f096678ff238f78324cadca002702efc9c50ae928,Finnhub
2025-03-31 07:02:49,Wall Street Breakfast Podcast: Chinese Tech Stops Slip,,https://finnhub.io/api/news?id=f302c065261f08610f268f1a34a701af31fdc678db17f85fca9fd4da0713fd9d,SeekingAlpha
2025-03-31 06:55:00,PGIM Jennison Growth Fund Q4 2024 Commentary,"The PGIM Jennison Growth Fund rose 6.5%, slightly underperforming the Russell 1000 Growth Index for Q4 2024. Click here to read the full commentary. ",https://finnhub.io/api/news?id=3f80a2cc5e443d35bd30910a4935fca083b85186e73e3e8f91cfaf0905c9ea6f,SeekingAlpha
2025-03-31 06:40:00,PGIM Jennison Focused Growth Fund Q4 2024 Commentary,,https://finnhub.io/api/news?id=737ff5ee66dd78153317776bacd4fec7f6e999436982756dea21c4a22bae1c46,SeekingAlpha
2025-03-31 04:45:00,John Hancock U.S. Growth Fund Q4 2024 Commentary,"For Q4 2024, the John Hancock U.S. Growth Fund underperformed the benchmark Russell 1000 Growth Index. Click here to read the full commentary. ",https://finnhub.io/api/news?id=bc200f8c1a9602b78c94fb644680e14dd05970f20a5f2aab6b5d98a5210183bb,SeekingAlpha
2025-03-30 07:13:00,1 Growth Stock With Major Catalysts on the Way to Buy and Hold,"After starting 2024 strong, Eli Lilly (NYSE: LLY) did not perform well in the second half of last year.  Its financial results, though solid compared to similarly sized peers, were not always up to investors' high standards for the market-leading drugmaker.  It's no secret that Eli Lilly is one of the leaders in the market for weight management drugs.",https://finnhub.io/api/news?id=ac48d667a17123b42f129397279f0040243a910c0bba09b22c94a25db65d5b8b,Yahoo
2025-03-30 07:10:00,abrdn World Healthcare Fund Q4 2024 Commentary,,https://finnhub.io/api/news?id=e424a624d3ccbbcf72e63c708c1d194dad5e933e215b0ca6eba6b0c429aa41cf,SeekingAlpha
2025-03-30 05:00:00,Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors,Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain for investors.,https://finnhub.io/api/news?id=e065d0a1e1188ee694cc2bc6539fc5b42f511784f8985ea5256abcfe2f272f87,SeekingAlpha
2025-03-30 03:25:00,abrdn Healthcare Opportunities Fund Q4 2024 Commentary,The equity portion of the Abrdn Healthcare Opportunities Fund fell (gross) but outperformed its custom benchmark over the quarter. Click here to read the full commentary.,https://finnhub.io/api/news?id=a5933eccf4e0954a3d6ef92d4832f42825c89b4de8dd9bba832d8a1bb2aa2d23,SeekingAlpha
2025-03-29 14:16:22,Eli Lilly and Company (LLY): Among Billionaire Ken Fisher’s Top Growth Stock Picks,"We recently published a list of Billionaire Ken Fisher’s Top 13 Growth Stock Picks. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other billionaire Ken Fisher’s top growth stock picks. “Who am I to tell you anything, much less anything that counts? Or that […]",https://finnhub.io/api/news?id=734b38def1c3e1ea6a784d1b862000e25b3aa52453abbd98049ceaca286c9564,Yahoo
2025-03-29 13:11:00,Go Big on Defense. It’s What Has Worked for Investors Three Months Into 2025.,Go Big on Defense. It’s What Has Worked for Investors Three Months Into 2025.,https://finnhub.io/api/news?id=4eb342cac224dd9dba20389f9ac2d29bdfbbe74950626849362469162f07fbd3,MarketWatch
2025-03-28 23:55:00,PGIM Jennison Blend Fund Q4 2024 Commentary,,https://finnhub.io/api/news?id=e8c81c0527072f874f76c8eb4c6106afdf4f82c6ccb52e4adcc553cb3fbe9e17,SeekingAlpha
2025-03-28 20:55:57,"Invest in UnitedHealth Group, not Eli Lilly: Good Buy or Goodbye","In the latest Good Buy or Goodbye, Regan Capital chief investment officer Skyler Weinand joins Market Domination host Julie Hyman to break down which stock is a good buy and what stock should be avoided. Weinand recommends investing in UnitedHealth Group (UNH), as the company is trading at an attractive P/E ratio. He also recommends avoiding Eli Lilly (LLY), as its tremendous revenue growth is hard to repeat. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",https://finnhub.io/api/news?id=163e60a8c12179f66f5736696dcbbc43119a4308e213c76a6f558349413c57c6,Yahoo
2025-03-28 20:30:24,"NEW YORK MARKET CLOSE: Shares lower on tariff strife, higher inflation",,https://finnhub.io/api/news?id=f5ccd156fe0b2afcfb033297dc05d233900e4cf52d26a1e9d4c945b7c97c596f,Fintel
2025-03-28 17:11:00,Health Care Roundup: Market Talk,Health Care Roundup: Market Talk,https://finnhub.io/api/news?id=ae3ddf31a880de1116406de17300190b2e0ca0b2f561542a89cdb452859a9f37,DowJones
2025-03-28 16:18:48,"European Equities Track Lower in Friday Trading; Apple, Meta May Face Lower EU Digital Markets Act Fines","The European stock markets were tracking lower in Friday trading as The Stoxx Europe 600 fell 0.69%,",https://finnhub.io/api/news?id=fe2ee1afdfe79b214892a683c768fe95cf950ae3f4162933498e01b4bb179cd6,Yahoo
2025-03-28 16:17:55,Novo Nordisk Inks Its Second Big Obesity Deal In A Week — And It's Not For A GLP-1,Novo Nordisk Inks Its Second Big Obesity Deal In A Week — And It's Not For A GLP-1,https://finnhub.io/api/news?id=dc03fc60b4ecb2ea593ade0a77b070f2d4c0e94ab19d88266ae407326477b63c,DowJones
2025-03-28 14:31:14,European committee says Lilly Alzheimer's drug shouldn't get marketing approval,"A European regulatory committee rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially dangerous risks of brain bleeding and swelling.  The European Medicines Agency committee said the benefits of the new drug, Kisunla, did not outweigh the risks, and it recommended refusing marketing authorization for it.  The agency’s Committee for Medicinal Products for Human Use said Lilly can ask for a re-examination of its opinion.",https://finnhub.io/api/news?id=258a1bfec0db204a6228c56c3c5c64a080641100fc67c8bc754b718595afd8a9,Yahoo
2025-03-28 13:33:09,Billionaire Ken Fisher’s #2 Low Vol Stock Pick: Eli Lilly & Company (LLY),"We recently published a list of 10 Low Volatility Stocks to Buy According to Billionaire Ken Fisher In this article, we are going to take a look at where Eli Lilly & Company (NYSE:LLY) stands against other low volatility stocks to buy according to billionaire Ken Fisher. Billionaire Ken Fisher, a prominent money manager, renowned […]",https://finnhub.io/api/news?id=bffcb3a9208b49f56d711e755d7c2e9020fc252c1f4a263a7dd9235c07bc5e26,Yahoo
2025-03-28 13:00:15,Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It,"Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",https://finnhub.io/api/news?id=fe23d84e23a5082e4c994f734fe992dc7c1e67b284a60c5793cb23cae3fd5d44,Yahoo
2025-03-28 13:00:00,"Tariffs, Tech Sluggishness, Gold, Bitcoin, And Inflation","Contextualizing auto tariff news for investors, tech sluggishness, Novo Nordisk, GameStop slide. Gold, Bitcoin, volatility and inflation.",https://finnhub.io/api/news?id=fad5c8f856e5b4cbcc85ebd4ffaa35bdfc7c47df4e1cdd0f526ae24f25438c9a,SeekingAlpha
2025-03-28 12:41:25,"BoFA says Novo Nordisk may miss Q1 expectations as Wegovy, Ozempic sales lag","Bank of America analysts on Friday said Novo Nordisk may miss first-quarter expectations, as sales of its blockbuster Wegovy and Ozempic drugs lag, which could prompt the Danish drugmaker to cut its 2025 guidance in its quarterly results.  BofA global research predicted in a note a 2% cut to the company's full-year sales guidance and expects a new sales growth range for the year of between 14% and 22%.  ""1Q seems a possible miss on sluggish Ozempic/Wegovy trends, worse currency (impact) and possibly higher (selling, general and administrative expenses) needed for demand creation and to convince physicians that supply is back,"" BofA said.",https://finnhub.io/api/news?id=248e4e5240cb3b49fb675e92ebc500b50c77dcd767fc8c0df7c1d1d1ca7b6f80,Yahoo
2025-03-28 12:01:25,CHMP Recommends Against Approval of Eli Lilly's Kisunla Alzheimer's Drug -- Update,"By Colin Kellaher A key European regulatory committee has recommended against approval of Eli Lilly's Kisunla, saying the benefits of the Alzheimer's disease drug don't outweigh its risks. ...",https://finnhub.io/api/news?id=138c73225112c6cc856c5e81f4f4480422f9511a32f6773596ea8eda6e10c7ce,Finnhub
2025-03-28 10:30:59,Eli Lilly adds Alzheimer’s treatment options to LillyDirect telehealth platform,"The platform features Healthgrades, a tool intended to connect Alzheimer's patients to experienced local clinicians.",https://finnhub.io/api/news?id=50365dc599c107090b4cb44f3a8ca8104a1395b16515ed91a8cb4283f0461d36,Yahoo
2025-03-28 09:44:42,AbbVie Vs. Sanofi: Which Is The Better Investment Right Now,,https://finnhub.io/api/news?id=2ec9b46a156413c058393a72e5bee50e867a91233b35571d7b5b27f08d74bd75,SeekingAlpha
2025-03-28 08:33:29,CHMP Recommends Against Approval of Eli Lilly's Kisunla Alzheimer's Drug,"By Colin Kellaher A key European regulatory committee has recommended against approval of Eli Lilly's Kisunla, saying the benefits of the Alzheimer's disease drug don't outweigh its risks. ...",https://finnhub.io/api/news?id=3989eef80c3b6468b72547e003df361e735c727210993c9e1fd8ea6cae0b9a15,Finnhub
2025-03-28 07:51:04,Eli Lilly Remains Confident In The Safety And Effectiveness Of Donanemab,Eli Lilly and Co: * ELI LILLY - REMAINS CONFIDENT IN THE SAFETY ANDEFFECTIVENESS OFDONANEMAB * ELI LILLY SAYS WILL SEEK RE-EXAMINATION BY CHMP - WEBSITEFurther company...,https://finnhub.io/api/news?id=e298a12de1a5f000fb0c538f89372ef44b280878ac3cfbcc57eb414ca740f9db,Finnhub
2025-03-28 07:45:00,"Billionaires Stanley Druckenmiller, Chase Coleman, and Stephen Mandel Jr. Are Piling Into This Growth Stock That's Beating the S&P 500","Each one of their moves may not be right for your particular investment strategy, but you may find certain ones that offer just what you're looking for.  If  you're looking for a low-risk growth stock that also happens to be outperforming the S&P 500 (SNPINDEX: ^GSPC) so far this year, it's time to consider a recent move made by three billionaires.  Stanley Druckenmiller of the Duquesne Family Office, Chase Coleman of Tiger Global Management, and Stephen Mandel Jr. of Lone Pine Capital each bought shares of a stock that operates in an industry known for steady performance, regardless of the market environment.",https://finnhub.io/api/news?id=30410eb3d7df995019f0e218147d988eea31075e4a3bc37b932955235d038553,Yahoo
2025-03-28 07:27:22,Negative recommendation in the EU for Eli Lilly's Alzheimer's drug Kisunla,"The European Medicines Agency's expert panel rejected pharmaceutical giant Eli Lilly's Alzheimer's drug Kisunla, pointing out that the risk of severe brain swelling does not outweigh the treatment's...",https://finnhub.io/api/news?id=6189c784b25595276c4a47a0a3b29b60eba220a5a7ab3a262f2655ef1a7a111b,Finnhub
2025-03-28 07:04:13,EU regulator rejects Eli Lilly's Alzheimer's drug,"The European Union's drugsregulator on Friday rejected Eli Lilly's Alzheimer'sdrug, saying the risk of serious brain swelling did not outweighthe treatment's small impact on slowing cognitive...",https://finnhub.io/api/news?id=771af3600e048796239c3834fae67d66cb72b345cdc6747d51af8949d2eaf66e,Finnhub
2025-03-28 06:59:57,EMA's CHMP Recommends Not Granting Marketing Authorisation For Eli Lilly's Kisunla,EMA's CHMP: * EMA'S CHMP: RECOMMENDED NOT GRANTING MARKETINGAUTHORISATIONFOR KISUNLA * EMA'S CHMP: RECOMMENDED TO REFUSE EXTENDING MARKETINGAUTHORISATION FOR PEMAZYRE...,https://finnhub.io/api/news?id=eee6b723d76863daff5002504d5a2366750f94ca8619bf2114274e676b7acd13,Finnhub
2025-03-28 06:53:10,EU medicines regulator rejects Eli Lilly's Alzheimer's drug,"The European Union's drugsregulator on Friday rejected Eli Lilly's Alzheimer'sdrug Kisunla, saying the risk of serious brain swelling did notoutweigh the treatment's small impact on slowing...",https://finnhub.io/api/news?id=e119ab71ddad8d1b0a3c5657ca7591b24b847fd8690a8b6fe322fa69f400459a,Finnhub
2025-03-27 20:47:50,Tracking Cliff Asness' AQR Capital Management 13F Portfolio - Q4 2024 Update,"AQR Capital Management's portfolio grew to $77.63B with top stakes in Apple, Nvidia, Microsoft, Amazon and Alphabet. Read here for a portfolio update.",https://finnhub.io/api/news?id=0f9f76ea1dfc19d71fbc8d6eed19477e768ee0f4440a5d4f249cf95c4ca85f2c,SeekingAlpha
2025-03-27 20:39:57,VIG: Index Rebalance Adds Eli Lilly To Bolster Dividend Growth In 2025,"VIG's recent rebalancing impacts its holdings, yield, and dividend growth streak. Read here for a comparison with SPY, DGRO, and DGRW ETFs.",https://finnhub.io/api/news?id=e51b13f6428a2a7cd526321e069d59dbfb99688748f82c2b210d4b938684310b,SeekingAlpha
2025-03-27 19:50:17,Eli Lilly and Company (LLY): Among Dividend Zombies to Invest in,"We recently published a list of 15 Dividend Zombies to Invest in. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other dividend zombies to invest in. The broader market has posted consecutive annual gains of 25%, largely fueled by growth stocks and companies capitalizing […]",https://finnhub.io/api/news?id=e239504768bcee0a66f6617d723f5a8906e58a4b90f6f846fa0dcb0664f47945,Yahoo
2025-03-27 17:29:18,"Novo shares on track for biggest monthly fall since 2002, investor worries grow","LONDON (Reuters) -Novo Nordisk shares have fallen 25% so far in March and are on track for their biggest monthly drop since July 2002, as investor worries intensify that the obesity drug market pioneer has lost its edge over U.S. rival Eli Lilly.  Novo came under pressure last year to prove it could keep its advantage in the lucrative obesity market after U.S. rival Lilly launched its own injection Zepbound, which led in clinical trials to greater weight loss than Wegovy.  That has not happened, say investors and analysts observing rapidly worsening market sentiment toward Novo, despite the fact that Wegovy sales more than doubled in the fourth quarter of last year.",https://finnhub.io/api/news?id=b57aa6a99b264d7b48fccf7f96f99f9b99c44aa4ea44b8bd35d3f90706a4065e,Yahoo
2025-03-27 17:27:16,Eli Lilly (NYSE:LLY) Expands Digital Platform For Alzheimer's Care As Shares Stay Flat,Eli Lilly (NYSE:LLY) announced an expansion of its LillyDirect digital healthcare platform to facilitate contact with healthcare providers for Alzheimer's patients—providing a targeted solution for timely diagnosis amid highlighted capacity issues. This aligns with a broader push in addressing Alzheimer's care and may be a factor behind Eli Lilly's 4% price rise over the last quarter. Other significant developments include promising phase 3 trial results for alopecia areata and the FDA's...,https://finnhub.io/api/news?id=974b0a42f74b5eee837f5fab81ac0121f8ccd98df9aa4b184bbbabc3ab2efae5,Yahoo
2025-03-27 13:15:00,Beyond GLP-1 Drugs: This Opportunity at Eli Lilly Could Surprise Everyone in 2025,"Mounjaro and Zepbound are Eli Lilly's largest sources of growth, but there is much more to the company.",https://finnhub.io/api/news?id=f05027003a8620411e6294f9c2aa46233193b0a97ff71d5202f4a92596f08d51,Yahoo
2025-03-27 13:00:00,LillyDirect platform expands to facilitate access to Alzheimer's disease care,"Eli Lilly and Company (LLY) has expanded its LillyDirect digital healthcare platform to offer connections to independent in-person and telehealth options for people in the U.S. living with Alzheimer's disease, the majority of whom have not been formally diagnosed.1",https://finnhub.io/api/news?id=bd6ac8d29333fba8209daa9339ceee494d05bba31568da1b9d8921068b2ab83e,Yahoo
2025-03-27 12:05:00,Organovo Provides Business Update,"SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) today provided a business update. With the closing of the sale of its FXR Program to Lilly (NYSE:LLY), Organovo has received upfront payments and anticipates future milestone payments. When combined with funding from previously reported warrant exercises and ad",https://finnhub.io/api/news?id=f5161b20293a2f94225de3e37f788758e32afd8373f20773783b66495416a576,Yahoo
2025-03-27 11:00:55,Investors in Eli Lilly (NYSE:LLY) have seen massive returns of 544% over the past five years,Long term investing can be life changing when you buy and hold the truly great businesses. And highest quality...,https://finnhub.io/api/news?id=98ae0d0e5d0e4ae878167a98d2943dd2e34a118e006830b905d9fe430ae46fd0,Yahoo
2025-03-27 10:50:00,Columbia Select Large Cap Growth Fund Q4 2024 Commentary,"For Q4 2024,  Columbia Select Large Cap Growth Fund Institutional Class shares returned 4.16%. Click here to read the full commentary. ",https://finnhub.io/api/news?id=f8efebf14f123d2251ca8a8d97d693d394238a78522ed0dd8e6451be3b82142c,SeekingAlpha
2025-03-26 21:04:31,Eli Lilly's GLP-1 pill could be the next key in obesity treatment,"Eli Lilly (LLY) will soon be releasing trial data on its small-molecule GLP-1 weight-loss pill, Orforglipron. The drug could be pivotal for the obesity treatment market due to its accessibility. Evan Seigerman, BMO Capital Markets managing director of biopharma equity research, joins Market Domination hosts Julie Hyman and Josh Lipton to share insights on the upcoming data release, supply chain challenges, and patient adherence issues. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",https://finnhub.io/api/news?id=c6127959358ae451561acf9443003a60d7ba2296e97308430042bfe0a61833c1,Yahoo
2025-03-26 20:13:08,US is only country debating GLP-1 insurance coverage for weight loss: Cigna CEO Cordani,Cigna (CI) CEO David Cordani is not convinced of the benefits of GLP-1s for weight-loss patients and said the US is the only country among developed nations where insurance coverage is being debated.,https://finnhub.io/api/news?id=64ce262c8731e0be72f6af4537f8d5b7c4747e2b9729830330fffd82f81d4f50,Yahoo
2025-03-26 18:41:08,Eli Lilly and Company (LLY): One of Two Sigma Investments’ Top Stock Picks,"We recently published a list of Top 10 Stocks to Buy According to Two Sigma Investments. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other top stocks to buy according to Two Sigma Investments. Two Sigma Investments, LP, a New York City-based hedge fund, […]",https://finnhub.io/api/news?id=389d4d1bbc060e4cd4090de283b6ea95aef837490b7c7c34a053f7dd142482cc,Yahoo
2025-03-26 16:43:36,Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study,"Viking Therapeutics stock skidded Wednesday despite the ""encouraging"" speed with which the company enrolled patients in an obesity study.",https://finnhub.io/api/news?id=0d4f518ba7629572f6a60fb8e820a28959a9985ee76efc4701cb171d672ac5eb,Yahoo
2025-03-26 16:31:00,Eli Lilly & Co. stock underperforms Wednesday when compared to competitors,Eli Lilly & Co. stock underperforms Wednesday when compared to competitors,https://finnhub.io/api/news?id=1c762dd625d67f2dd78f4511c02b871aad98fcd82d7498511c181a50b151bb64,MarketWatch
2025-03-26 14:55:00,Franklin Growth Opportunities Fund Q4 2024 Commentary,"US stocks collectively rose in the fourth quarter of 2024, with the S&P 500 Index, Dow Jones Industrial Average and NASDAQ Composite Index reaching new record highs.",https://finnhub.io/api/news?id=826ddcf2b816d7f94d478f285163d5524026b26fe06f36a5cf4101ba2c492472,SeekingAlpha
2025-03-26 10:17:09,The Risk/Reward Of Avidity Biosciences And Its 2 Promising Programs,"Avidity Biosciences, Inc.'s innovative AOC platform and promising clinical programs make it a high-risk, high-reward investment. Read more on RNA stock update.",https://finnhub.io/api/news?id=e9c604309b041827af4cb535b2f3a76212b25575ce814704f2600525c158cd74,SeekingAlpha
2025-03-26 10:05:00,2 No-Brainer Growth Stocks to Buy and Hold Forever,"Don't let market volatility convince you otherwise: Investing in stocks remains one of the best ways to accumulate capital over long periods.  Companies that can last -- and thrive -- that long are rare, but let's consider two brilliant examples investors should strongly consider today: Eli Lilly (NYSE: LLY) and Shopify (NYSE: SHOP).  Eli Lilly, a leading pharmaceutical company, develops and markets therapies across various areas, including immunology, oncology, and especially endocrine disorders like diabetes.",https://finnhub.io/api/news?id=21479c5be8be2fd71afd5abedb20ba136698b09cab2af9f24f115725d85ebd9c,Yahoo
2025-03-26 03:20:56,Foghorn: SMARCA4 Targeting Brings About Treating Up To 10% Of NSCLC Patients,"Foghorn Therapeutics advances FHD-909 for SMARCA4 tumors, backed by Eli Lilly partnership. Read here to know why we are neutral on FHTX stock.",https://finnhub.io/api/news?id=7ca6d1abe07cc7ab333d46c5dcd79ade8fa861404ae3f4681b7986c49dbbc5b0,SeekingAlpha
2025-03-25 21:45:15,Eli Lilly (LLY) Stock Sinks As Market Gains: Here's Why,"Eli Lilly (LLY) closed at $852.35 in the latest trading session, marking a -1.45% move from the prior day.",https://finnhub.io/api/news?id=40a57910db8a84200a44ed9797b5ea0a3fcc621edae9a430904380830726040a,Yahoo
2025-03-25 20:59:26,Tracking Lone Pine Capital Portfolio - Q4 2024 Update,Lone Pine Capital's 13F portfolio value increased slightly from $13.41B to $13.47B. Check out the new stakes and significant stake additions to the portfolio.,https://finnhub.io/api/news?id=7b599a8cc87451e8f3c15fbf0e8c8056afc2603d09bb2b497796a664af570470,SeekingAlpha
2025-03-25 20:35:00,Lilly announces details of presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting,"Eli Lilly and Company (NYSE: LLY) today announced that preclinical data for agents targeting SMARCA2 (BRM) and multiple KRAS mutations will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 25 - 30 in Chicago.",https://finnhub.io/api/news?id=473a20ed9eac2cfccf2e015b3a676bd938b51b6f9bc4501699cbc45ef9cda43b,Yahoo
2025-03-25 18:26:00,"GLP-1s are driving returns on R&D investments for Big Pharma, report says",Big Pharma is expected to see big returns from its investment in a class of drugs made famous by Novo Nordisk’s (NVO) popular diabetes drug Ozempic.,https://finnhub.io/api/news?id=886287b88e14d44d8f090a00ca58279cf999ba6245f33e182435699cad6640f8,Yahoo
2025-03-25 16:04:00,"Novo Nordisk Expands Wegovy Price Cut Program, Stock Still Falls 2%",NVO's shares are down 2% despite making Wegovy available at a discounted price of $499 per month at local pharmacies.,https://finnhub.io/api/news?id=c54bc4c90accbd722a99816e3d4e7a4fc9f5074e0f7a61496455cf89a9d3b579,Yahoo
2025-03-25 16:01:48,Novo Nordisk earmarks $2bn for Chinese “triple G” weight loss shot,Novo Nordisk is making plans for a Wegovy successor amid uncertainty surrounding CagriSema.,https://finnhub.io/api/news?id=79340303734b44745e7e33aef684622dc72ae572e767606d47da50d287ff8b37,Yahoo
2025-03-25 15:25:00,Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company,"SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD), today announced the successful close of the sale of its FXR program, including lead asset FXR314, to Eli Lilly and Company (NYSE:LLY) (“Lilly”). The transaction was completed on March 25, 2025. With the closing, Organovo receives an upfront payment, with futur",https://finnhub.io/api/news?id=5ed05a43c7de10ebb2c738d0a0f12b3f90300116e9e22292e78ce6b5de49f82e,Yahoo
2025-03-25 13:43:59,Is Eli Lilly and Company (NYSE:LLY) The Best Stocks to Buy Now For the Long Term?,"We recently published a list of 10 Best Stocks to Buy Now For the Long Term. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best stocks to buy now for the long term. What’s Next for the Equity Markets? The US equity markets […]",https://finnhub.io/api/news?id=6e8bd1d1b62e03f0e1a9eb5f6dc853d5255c3932f45016a139703e1bafd266ee,Yahoo
2025-03-25 12:03:17,Trump tariffs drive pharma manufacturing to US but risk inflation and disruption,"Pressure may grow on companies to repatriate production, raising production costs and potentially medicine prices too.",https://finnhub.io/api/news?id=5765941ca9210f9b96735c2a938c56302f7f3449ba1628457c22c1d86bcdda4b,Yahoo
2025-03-25 07:28:30,Verve Therapeutics: HeFH Treatment Program Of VERVE-102 Remains On Track With 2025 Catalysts,"Verve received FDA IND clearance for VERVE-102 to treat HeFH, adding new trial sites in the United States. Read more about VERV stock here.",https://finnhub.io/api/news?id=4a4e0fad7ee64a4cfb33be3eff4d8f947b3c87dde44110e15f82bfa247edd11a,SeekingAlpha
2025-03-25 06:56:00,"Trump Tariff Uncertainty Will Break This Stock Market Calm, Brace for Another Storm. And 5 Other Things to Know Today.","Trump Tariff Uncertainty Will Break This Stock Market Calm, Brace for Another Storm. And 5 Other Things to Know Today.",https://finnhub.io/api/news?id=1b79a994a2f0e264778ce8249c13bdfd5b7126323df55985dd4c80993c2e7d85,MarketWatch
2025-03-25 04:00:41,GLP-1s boost pharma R&D projected return on investment: Deloitte,Companies looking to compete in the GLP-1 market are adding value to the R&D spend across the pharma sector.,https://finnhub.io/api/news?id=8adb0a519bc25dd494f5bcd6fc0b384cd8459411a521b30b3433ae71c7024ad5,Yahoo
2025-03-25 04:00:41,GLP-1s boosts pharma R&D projected return on investment: Deloitte,Companies looking to compete in the GLP-1 market are adding value to the R&D spend across the pharma sector.,https://finnhub.io/api/news?id=846e93beccf8749989fa036b89e3f18ab0441710d5c9ae0274d16c05f0595593,Yahoo
